top of page
ATHENA
BEVACIZUMAB PLUS CHEMOTHERAPY IN LOCALLY RECURRENT OR METASTATIC BREAST CANCER
CLINICAL TRIAL DETAILS
BEVACIZUMAB PLUS CHEMOTHERAPY IN LOCALLY RECURRENT OR METASTATIC BREAST CANCER.
---
COUNTRY
STATUS
TUMOR TYPE
PHASE
N
SITES
BREAST
15
120.0
II
Spain
SETUP
TRIAL OVERVIEW
PRESS RELEASE
----
SCIENTIFIC IMPACT
----
BLOG ARTICLES RELATED
----
TRIAL SITES
----
Dr. Cortes and Dr. Llombart PHERain interview
Beyond Chemotherapy
Dr. Vanes Quiroga
Dr. Sofia Braga
Dr. Silvi AntolÃn
Dr. Escrivá de RomanÃ
Dr. Philipp Aftimos
Dr. Manuel Ruiz
Prof. Daniele Generali PHEGain interview
Dr. Jacques Medioni
Dr. Dunca Wheatley
bottom of page